XOMA Q1 2026 Earnings Royalty Revenue Challenges Lead to EPS Miss Stock Slips CDP Q1 2026 Earnings Modest EPS Beat Amidst Steady DefenseOriented Portfolio authID Inc Q1 2026 Earnings Continued Losses as Revenue Yet to Materialize HEI Q4 2025 Earnings EPS Surprise Beats Estimates Despite Tepid Market Response Adagene Q2 2025 Earnings EPS Misses Estimates Amid Operational Progress IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances